Skip to main content
Cellular Oncology logoLink to Cellular Oncology
. 2021 Aug 19;44(5):1207. doi: 10.1007/s13402-021-00627-8

Retraction Note: Human bone marrow-derived mesenchymal stem cell-secreted exosomes overexpressing microRNA-34a ameliorate glioblastoma development via down-regulating MYCN

Bin Wang 1,2,3, Zhong-Hua Wu 1,2,3, Ping-Yang Lou 1,2,3, Chang Chai 4, Shuang-Yin Han 5, Jian-Fang Ning 6, Ming Li 1,2,3,
PMCID: PMC12980734  PMID: 34398441

Retraction Note: Cellular Oncology https://doi.org/10.1007/s13402-019-00461-z

The Editor-in-Chief has retracted this article. After publication, the corresponding author stated that he has been unable to reproduce the targeting relationship between miR-34a and MYCN in animal experiments. Additionally, the authors have been unable to provide documents confirming that ethics approval was obtained for this study. The Editor-in-Chief therefore considers the data reported in this the article to be unreliable.The authors have not responded to correspondence regarding this retraction notice.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Change history

12/3/2023

A Correction to this paper has been published: 10.1007/s13402-023-00900-y


Articles from Cellular Oncology are provided here courtesy of Springer

RESOURCES